BSX

NYSE

BOSTON SCIENTIFIC CORP

Latest disclosureSeptember 3, 2026

Insider score Why 60?: 60/ 100
Qualifying buys · 30d: $0

10 purchases · 0 sales

Price by TradingView

Insider transactions 41

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 10 trades on this page.

Purchase disclosed

Susan E. Morano

Director

Common Stock

Reported value: $100.41K
Reported price: $49.2195 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $99.94K
Reported price: $47.589 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $50.08K
Reported price: $48.0655 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $6.8K
Reported price: $48.5879 / share

Purchase disclosed

Michael F. Mahoney

Chairman, President & CEO

Common Stock

Reported value: $9M
Reported price: $48.3323 / share

Purchase disclosed

Edward J. Ludwig

Director

Common Stock

Reported value: $227.4K
Reported price: $45.4799 / share

Purchase disclosed

Cheryl Pegus

Director

Common Stock

Reported value: $99.99K
Reported price: $56.49 / share

Purchase disclosed

Edward J. Ludwig

Director

Common Stock

Reported value: $202.91K
Reported price: $56.68 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $125.28K
Reported price: $56.9451 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $125.82K
Reported price: $55.9195 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Common StockPurchase	2,040$49.22 / share	$100.41K	Aug 25Filed Aug 26 · 1d later	SEC filing
Director	Common StockPurchase	2,100$47.59 / share	$99.94K	Aug 5Filed Aug 7 · 2d later	SEC filing
Director	Common StockPurchase	1,042$48.07 / share	$50.08K	Aug 3Filed Aug 5 · 2d later	SEC filing
Director	Common StockPurchase	140$48.59 / share	$6.8K	Aug 4Filed Aug 5 · 1d later	SEC filing
Chairman, President & CEO	Common StockPurchase	186,240$48.33 / share	$9M	Aug 3Filed Aug 5 · 2d later	SEC filing
Director	Common StockPurchase	5,000$45.48 / share	$227.4K	Jul 31Filed Aug 3 · 3d later	SEC filing
Director	Common StockPurchase	1,770$56.49 / share	$99.99K	May 20Filed May 21 · 1d later	SEC filing
Director	Common StockPurchase	3,580$56.68 / share	$202.91K	May 20Filed May 21 · 1d later	SEC filing
Director	Common StockPurchase	2,200$56.95 / share	$125.28K	May 19Filed May 21 · 2d later	SEC filing
Director	Common StockPurchase	2,250$55.92 / share	$125.82K	May 20Filed May 21 · 1d later	SEC filing

Congress transactions 26

All Congress filings

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: September 9, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: September 4, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: August 31, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 18, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 4, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 29, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 19, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 11, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 10, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 30, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a purchase for a joint account.

Markwayne MullinReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Partial sale disclosed

Boston Scientific Corp · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 17, 2025

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 24, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 31, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 17, 2025

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: October 28, 2025

Showing the latest 25 of 26 disclosed trades. Show all 26 trades

Why this buying score?

Qualifying common-equity purchase value

$5,375,903 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+19 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+8 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+8 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000885725
Latest public acceptance: Sep 3, 2026, 08:34 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Director

Common StockPurchase

2,040$49.22 / share

$100.41K

Aug 25Filed Aug 26 · 1d later

SEC filing

Director

Common StockPurchase

2,100$47.59 / share

$99.94K

Aug 5Filed Aug 7 · 2d later

SEC filing

Director

Common StockPurchase

1,042$48.07 / share

$50.08K

Aug 3Filed Aug 5 · 2d later

SEC filing

Director

Common StockPurchase

140$48.59 / share

$6.8K

Aug 4Filed Aug 5 · 1d later

SEC filing

Chairman, President & CEO

Common StockPurchase

186,240$48.33 / share

$9M

Aug 3Filed Aug 5 · 2d later

SEC filing

Director

Common StockPurchase

5,000$45.48 / share

$227.4K

Jul 31Filed Aug 3 · 3d later

SEC filing

Director

Common StockPurchase

1,770$56.49 / share

$99.99K

May 20Filed May 21 · 1d later

SEC filing

Director

Common StockPurchase

3,580$56.68 / share

$202.91K

May 20Filed May 21 · 1d later

SEC filing

Director

Common StockPurchase

2,200$56.95 / share

$125.28K

May 19Filed May 21 · 2d later

SEC filing

Director

Common StockPurchase

2,250$55.92 / share

$125.82K

May 20Filed May 21 · 1d later

SEC filing

Why this buying score?

Qualifying common-equity purchase value

$5,375,903 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+19 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+8 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+8 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000885725
Latest public acceptance: Sep 3, 2026, 08:34 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.